CME and CFTC Engage in Intense Battle Over On-Chain Perpetual Futures

The conflict between the CME Group and the US Commodity Futures Trading Commission (CFTC) has escalated, with the CME suing the CFTC over its decision to allow blockchain-based perpetual futures products. The CME argues that these products, which enable users to speculate on asset prices with leverage and no expiration date, are being mislabeled and misregulated. The lawsuit claims that the CFTC's sudden endorsement of perpetual futures did not consider the potential consequences and could harm the CME's long-dated futures products. The CFTC's move has been seen as a significant development in the rapidly growing arena of perpetual futures, with non-US volumes reportedly reaching $60 trillion last year. The CME's chairman, Terry Duffy, has been vocal in his opposition to the CFTC's stance, arguing that the regulator is not following established protocols and may not be prepared to enforce its emerging policy properly. The dispute has sparked frustration among those supporting the CFTC's reform agenda, with some viewing the CME's actions as an attempt to maintain its dominance in the market. The outcome of the lawsuit is expected to have significant implications for the US approach to perpetual futures and the broader crypto industry.